Lupin breaks into Dow Jones sustainability indices after scoring 91/100 in global ESG assessment
The pharmaceutical company’s inclusion comes as ESG-linked disclosures and governance standards gain greater weight among global investors and healthcare buyers.

What's Your Reaction?











